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Objective: Unplanned pregnancy in women with SLE can have grave complications both for the child and the
woman. We studied the prevalence of contraceptive counseling among women of reproductive age with SLE at a
university hospital in Northeast Thailand.
Methods: Recruited: 125 women with SLE, between 15 and 50 years, followed up at the Rheumatology Clinic. A
questionnaire was administered and the results analyzed to identify the prevalence of contraceptive counseling.
Results: The majority of women with SLE had had their reproductive goals evaluated (76.00%, 95% CI 66–83) and
received contraceptive counseling (72%). Among the SLE patients at risk for pregnancy, only one-third used
effective contraception and one-fifth of those did not have any background knowledge about SLE and pregnancy.
Contraceptive counseling was more frequently given to women who had had a previous pregnancy or who were
already concerned about SLE as related to pregnancy.
Conclusion: The majority of SLE patients had at one time or other received contraceptive counseling, but some
reported not grasping the gravity. The survey results presented herein suggest that a multidisciplinary team is
needed to improve patient knowledge regarding SLE as it affects on pregnancy and relatedly contraceptive
counseling.Introduction
Systemic lupus erythematosus (SLE) is a systemic auto-
immune disease mostly found among women of re-
productive age [1]. There is no official report on the
prevalence of SLE among the Thai population. An epi-
demiologic study using a questionnaire survey of 2,463
subjects of rheumatic diseases in rural Thailand by
Chaiamnauy et al. reported that the prevalence of CNTD
was 8 in 10,000 [2]. In 2001, a community survey of
musculoskeletal pain and management in Namphong
District, Khon Kaen Province conducted by Auabandit
et al. revealed the prevalence of SLE was 0.38% [3].* Correspondence: yutwer@kku.ac.th
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reproduction in any medium, provided the orA 2009 study [4] of pregnancy outcomes among women
with SLE at Srinagarind Hospital showed 37 women with
SLE were pregnant in the 10 years between 1997 and
2006; 90% of whom had had SLE established before preg-
nancy. The disease was active during pregnancy in two-
thirds and correlated with poorer pregnancy outcomes. In
this group, the disease activity during pregnancy was a
continuation from the pre-pregnancy period for 60% of
the women; thus, ~40% of SLE patients became pregnant
during an active disease phase.
During pregnancy, lupus improves in a third of wom-
en, remains unchanged in a third, and worsens in the
remaining third. Thus, in any given pregnancy, the clinical
condition can worsen or flare without warning. Common
complications in a cohort of 13,555 women with SLE dur-
ing pregnancy are pregestational diabetes, preeclampsia,
renal failure, preterm labor, fetal-growth restriction, neo-
natal lupus, etc [5]. In general, pregnancy outcome isl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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6 months before conception (2) There is no active renal
involvement manifest by proteinuria or renal dysfunction
(3) Superimposed preeclampsia does not develop and (4)
There is no evidence of antiphospholipid antibody activity
[6]. For a better pregnancy outcome, women of reproduct-
ive age with SLE should receive preconception counseling
and use contraception, hence they would know when is
the right time that they can get pregnant. Due to the ser-
iousness of the risks, we performed an observational study
at Srinagarind University Hospital to determine (a) the
prevalence of contraception counseling among women of
reproductive age with SLE (b) the method of contracep-
tion used and (c) the factors associated with the use of
contraception.
Material and methods
Study population: Included in the study were 125 women
between 15–50 year of age, either who were pregnant or
not, in remission or still in the active phase, diagnosed
SLE and being followed up at the Rheumatology Clinic,
Srinagarind Hospital. The sample size was determined by
a pilot study of 10 SLE women who achieved criteria. The
volunteers were interviewed independently for about 30
minutes by an obstetrician or a rheumatology nurse. The
questionnaire included questions on (a) SLE manifesta-
tions and activity (b) sociodemographics (c) obstetric and
gynecologic history and (d) knowledge about reproductive
health and basic knowledge about SLE disease as related
to pregnancy.
All patients were diagnosed with SLE by a rheumatolo-
gist. These diagnoses were confirmed during a formal re-
view of the medical records as per the Revised Criteria
of the American Rheumatism Association for the Classi-
fication of Systemic Lupus Erythematosus (SLE).
The study procedures were approved by the Human
ethics committee of faculty of medicine Khon Kaen
University (June 24, 2011).
Measures
Reproductive history was available for 125 participants.
The information included (i) total number of pregnancies
(ii) whether the pregnancy occurred after diagnosis of
SLE (iii) whether the pregnancy was planned or not, (iv)
the pregnancy outcomes (i.e., early miscarriage, induced
abortion for any cause, late miscarriage or stillbirth) (v)
any gynecologic operation (viz., tubal resection, hysterec-
tomy or salpingectomy) and (vi) the menstrual pattern.
The volunteers were also interviewed about their edu-
cational status, marital status, income per month, dis-
ease duration and any disease activity (i.e., active with
renal involvement, active without renal involvement or
inactive disease). The medical records were reviewed for
any indication of a potential teratogen used (i.e., MTX,MMF, cyclophosphamide or warfarin) or any evidence of
thrombosis event (viz., stroke, myocardial ischemia, DVT,
PE or renal vein thrombosis).
The 125 women with SLE were asked, “Have you ever
been asked about your reproductive goals?” If yes, we
determined the number of women who had been asked
if they had received contraceptive counseling. We then
evaluated the pregnancy risk. Women who were not
sexually active (have not had sexual intercourse for at
least 3 months), were in menopause or had had a hyster-
ectomy or tubal resection were not at risk for pregnancy;
all others were defined as at risk for pregnancy. This
group were not queried about their knowledge or atti-
tudes because they did not need contraceptive counsel-
ing anymore.
All women were asked about the method of contracep-
tion used. We then evaluated the effectiveness of the
method: hormonal contraception and IUD method counted
as effective contraception, even if not used consistently.
Women who used ineffective contraception were evalu-
ated for their background knowledge of SLE disease as it
relates to pregnancy via 3 questions: (1) “Did you know
that women with SLE can get pregnant and that the med-
ications that control the disease or the disease itself may
affect the pregnancy outcome?” (2) “Did you know that
pregnancy can aggravate SLE activity?” and (3) “Did you
know that women with SLE should avoid getting pregnant
if the disease has been inactive for less than 6 months?”
Woman who could not answer at least 2 of the 3 forego-
ing questions were considered as ‘not having background
knowledge of SLE disease as related to pregnancy’.
In women who did not use contraception, the reasons
for not using it were recorded. Among women who had
been asked about their reproductive health, we evalu-
ated their perception of contraceptive counseling with
the following questions: (1) “Have you ever received any
contraceptive counseling?” (2) If so, “Did you understand
the counseling given?” The women not at risk for preg-
nancy were categorized as having correctly understood
the risks because they did not need contraceptive coun-
seling anymore.
The pregnant women enrolled in this research were
asked (1) whether they had received contraceptive coun-
seling (2) the method of contraception they used before
pregnancy (3) their background knowledge regarding SLE
disease as related to pregnancy and (4) their intention for
pregnancy.Statistical analysis
The sociodemographic characteristics, SLE manifestation
and activity, obstetric- gynecologic history, history of get-
ting contraceptive counseling and the knowledge of SLE
disease related to pregnancy of the study volunteers are
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ard deviations as appropriate.
The women at risk for unplanned pregnancy group
were further analyzed using univariate logistic regression
to identify the factors associated with effective contra-
ception use and associated with receiving contraception





• Less than elementary education
• Secondary education









• < 10,000 THB per month
• 10,000-30,000 THB per month
• > 30,000 THB per month
SLE activity in the past 6 months
• Active with renal involvement










Total pregnancies among those ever pregnant
Being pregnant, unplanned
Women pregnant after diagnosed SLE
• Total pregnancies after diagnosed SLE
• Unplanned (n = 13)
Live births (n = 56)
Early miscarriages (n = 12)
Induced abortions (n = 11)
• Uncontrolled severe SLE
• Socioeconomic/psychosocial causestatus, taking teratogenic medication, active disease with
renal involvement, disease duration, healthcare provider
(i.e., rheumatologist or obstetrician), history of prior preg-
nancy and bad obstetric outcome (e.g., induced abortion,
other pregnancy complication) and patient, partner and
the family’s desire to have a child. With each associated
variable, the multivariate logistic regression was run anew.istories of women between 15 and 50 years with SLE
Frequency/mean ± SD Percent/range
33.48 ± 9.3 15-50






















1.97 ± 0.92 1-5
7 5.60%
24 19.24%
1.46 ± 0.78 1-4
1.31 ± 0.85 1-4
1.91 ± 0.82 1-5
1.083 ± 0.29 1- 2
1.09 ± 0.30 1-2
6/11 54.55%
5/11 45.55%
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A total of 125 women of reproductive age (15–50 years)
with SLE were interviewed. The sociodemographic char-
acteristics, SLE disease activity and disease’s related
complications are summarized in Table 1. Over one-half
of the lupus patients were married or living with a part-
ner (56.8%). One-third (33.6%) had active disease with
renal involvement, whereas 8.0% and 21.6%, respectively,
had a history of thrombosis and potential teratogenic
drugs use.
The reproductive history of each patient is also sum-
marized in Table 1. More than one-half of the patients
had been pregnant (71; 56.8%): of the 24 (19.24%) who
got pregnant after diagnosis of SLE; half of them (10.4%)
were unplanned pregnancies. Therapeutic abortion was
indicated for 11 (8.8%) patients; 6 cases due to uncon-
trolled active SLE (3 unplanned vs. 3 planned pregnancy)
and 5 due to socioeconomic or psychological reasons.
SLE patients were categorized by risk of pregnancy
(Table 2). A majority (82/125; 65.6%) of the SLE patients
followed up had no risk for pregnancy, either because of
their postmenopausal status, not being sexually active
for at least 3 months, or the existence of some other co-
morbid condition obviating pregnancy. Some patients
may have had more than one factor. A minority of pa-
tients (43/125; 34.4%) were at risk for pregnancy; among
whom most (35/43; 81%) were not worried about whether
or not they got pregnant so they were defined as women
at risk for unplanned pregnancy.
Contraception use among women at risk for un-
planned pregnancy is shown in Table 3. Only 37.1%
reported use of effective contraception (viz., hormonal
method or IUD). However, less than one-half of them
reported consistent use of contraception. Another worri-
some factor was the misunderstanding of the women at
risk for unplanned pregnancy that they could not get
pregnant because of their having a chronic disease, or
infrequent sexual intercourse so there was no need for a
contraceptive.
Contraception use and counseling among women of
reproductive age with SLE is presented in Table 4. SomeTable 2 Pregnancy risk of woman age < 50 years with SLE
Pregnancy risk and intention (n = 125)
• Not at risk; three variables overlapped
○ Menopause
○ Not sexually active in last 3 months
○ Other medical/surgical conditions (included TR, hysterec
• At risk for pregnancy
○ Pregnant
○ Trying to become pregnant
○ Not trying to become pregnant OR not considered24.0% (30 of 125) of the participants had never been
asked about their reproductive goals or had forgotten,
5.6% (7 of 125) of these were at risk for pregnancy. A
small 3.2% (4 of 125) of this group did not use contracep-
tion and 1.6% (2 of 125) did not have basic knowledge
about SLE disease as related to pregnancy. Of the 125
women with SLE, 95 (76.8%; 95% CI 68–83) reported hav-
ing been asked about their reproductive goals: 36 (28.8%)
were at risk for pregnancy (1 of them tried to become
pregnant); 1 (0.8%) reported she did not know about or
use effective contraception to prevent aggravation of the
SLE. Some 3.2% (4 of 125) had been asked about their re-
productive goals, whether they were at risk for pregnancy,
whether or not they used contraception and their know-
ledge about SLE as related to pregnancy.
Most (90/125; 72.0%; 95% CI 63–79) remembered hav-
ing been given contraceptive counseling, and only 39
(11.2%; 95% CI 6–18) reported not having understood.
Since they did not need any contraceptive counseling,
we included all the women in the ‘received contraceptive
counseling group’ who were: in menopause, had had
tubal resection or hysterectomy, or were not sexually ac-
tive. The majority of counseling providers were rheuma-
tologists (50.4% vs. 8.0%) (Table 5).
In Table 6, we focused on pregnant women. One
woman (0.8%) reported that she had never been asked
about her reproductive health or goals, did not use con-
traception, did not have any background knowledge about
SLE disease as related to pregnancy and had an un-
planned pregnancy. Six of the 125 (4.8%) women reported
they had been asked about their reproductive goals, 4
(3.2%) used contraception vs. 2 (1.6%) who did not.
Among the pregnant women who had been asked about
and used contraception, 1 (0.8%) used ineffective contra-
ception (condom), did not have knowledge about SLE
as related to pregnancy and had a planned pregnancy
whereas 3 (2.4%) used effective contraception (COC) al-
beit inconsistently, had knowledge but had an unplanned
pregnancy. We found that among the women who had
been asked, 2 (1.6%) did not use contraception, did not








Table 3 Contraception use among women at risk for
unplanned pregnancy (n = 35)
Frequency of contraceptive use in past 3 months
• Never 12/35 (34.29%)
• Sometimes 7/35 (20.00%)
• Always 16/35 (45.71%)
Method of contraception used in past 3 months
• None (including withdrawal and rhythm) 12/35 (34.29%)
• Combined oral contraceptive pill 7/35 (20.0%)
• Progestin injection 3/35 (8.57%)
• Progestin implantation 2/35 (5.71%)
• IUD 1/35 (2.86%)
• Condom 10/35 (28.57%)
Reasons for not using contraception among those not trying to get
pregnant (n = 12)
• Believe that they could not get pregnant
because of having a chronic disease
3/12 (25.0%)
• Believe that infrequency of sexual intercourse
obviated the possibility of getting pregnant
2/12 (16.66%)
• Others 7/12 (58.33%)
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pregnancy’ if (a) they did not try to get pregnant or (b)
did not consider getting pregnant (Table 2). We then
performed univariate logistic regression to evaluate the
variables associated with using effective contraceptionTable 4 Contraceptive use, counseling and basic knowledge o
reproductive age (n = 125)
Had been asked about desire to be pregnant
Not at risk for pregnancy




Do not have knowledge
Non-contraceptive use
Have knowledge*
Do not have knowledge
Had never been asked about desire to get pregnant
Not at risk for pregnancy





Do not have knowledge
* Effective contraception means using any hormonal method or IUD, unless it was a
condom. Other methods including rhythm and withdrawal. were categorized as noand receiving contraceptive counseling (Table 7). Four
of the 17 variables were associated with receiving con-
traceptive counseling—including prior pregnancy and 3
variables on basic knowledge of SLE disease as related to
pregnancy. But when further analyzed using multivari-
able logistic regression, the 3 knowledge variables were
not statistically significant (Table 8).
Discussion
The definition of contraceptive counseling is using of
interpersonal communication skills to effectively provide
information that will help the woman decide on her
contraceptive needs. From a rheumatological perspective,
the first step is to ask the woman about her reproduc-
tive desires or goals: does she or do she and her partner/
family want to get pregnant. In our research, 76% of the
women reported that they had been asked this sort of
question and 28.8% of them were at risk for pregnancy
although only one-third of them used effective contracep-
tion. Another 18.4% of the women either used no contra-
ception or ineffective contraception and one-fifth of this
group did not have basic knowledge about SLE as related
to pregnancy. We did not ask when the last time that they
had received contraceptive counseling was so we cannot
define whether the counseling affected contraceptive use
or not.
In the questionare, we questions about “not sexually
active”, it was uncertained that they still not sexuallyf SLE as related to pregnancy among women with SLE of
Frequency Percent


















lready defined as ineffective; ** Ineffective contraception means using a
n-contraception.
Table 5 Perception of contraceptive counseling among
woman between 15 and 50 years with SLE
N = 125 Frequency Percent (95% CI)
Had ever been asked about their reproductive health/goals?
• Never 29 23.2
• Yes 96 76.8 (68–83)
Among those asked, Had they ever received contraceptive counseling?
• Never 4 3.2
• Forgot 2 1.6
• Yes* 90 72.0 (63–79)
Level of understanding among women who had received contraceptive
counseling (n = 90)
• Understood 34 60.8 (52–69)
• Not well 39 11.2 (6–18)
Counseling provider among women who had received contraceptive
counseling (n = 90)
• Rheumatologist 63 50.4 (41–59)
• Obstetrician 10 8.0 (3–12)
* Included the women who were in menopause, not sexually active, had
undergone TR or hysterectomy.
Table 6 Contraceptive counseling among being pregnant
women with SLE 15–50 yearsn = 125
Frequency Percent
Being pregnant 7 5.6
Had never been asked about desire to get
pregnant
1 0.8
No contraception 1 0.8
Had been asked about desire to get pregnant 6 4.8
Using effective contraception but
inconsistent
3 2.4
Using ineffective contraception 1 0.8
No contraception 2 1.6
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“not at risk for pregnancy” at the time we studied. How-
ever, this group should also received contraceptive coun-
seling to prevent unplanned pregnancy.
Although most women at risk for unplanned preg-
nancy use contraception, barrier methods with a high
rates of failure [7] were the most commonly used, even
among those with a history of thrombosis. Importantly,
we found that in the non-contraception group at risk for
unplanned pregnancy, some did not even realize that
they could become pregnant and thus thought that con-
traception was unnecessary. Moreover, most of being
pregnant women had ever received contraceptive coun-
seling, but got unplanned pregnancy. Clearly, patients
need more background knowledge about their repro-
ductive health as it relates to SLE and how to appropri-
ately use contraception.
In the current study, we found that only a small num-
ber of women were referred to the Family Planning Unit.
Four variables were associated with receiving contracep-
tive counseling (a) know that women with SLE can get
pregnant (b) know that the medications controlling the
disease can affect the pregnancy outcome (c) know that
pregnancy itself can aggravate SLE and (d) have been
pregnant before, but when we analyzed the first three
dependent variables in a multivariate logistic regression,
they were not statistically significant—perhaps because
they confounded each other. Effective counseling never-
theless needs to convey the basics of SLE disease as re-
lated to pregnancy.
The benefit of study is to make physicians and nurses
aware of the need for contraceptive counseling for womenwith SLE, including other medical diseases. The limitation
for a study with a secondary objective was the small sam-
ple size; consequently, the outcome of associated factors
could not be fully analyzed. Further study may be re-
quired. For Women using hormonal contraception incon-
sistently should not be considered as using “effective”
contraception, it might reduce the generalizability of the
paper.
According to a previous study at the University of
California [8], the only significant predictive factor for
receiving contraception counseling was a prior preg-
nancy. The other important variable was healthcare pro-
vided by an obstetrician-gynecologist; possibly because
women prefer getting contraceptive counseling from an
obstetrician rather than a rheumatologist. In the current
study, we could not make any conclusions about this
variable because of the different proportion of patients
served between obstetrician and rheumatologist. Never-
theless, both the attending rheumatologist and the con-
sulting obstetrician should encourage women with SLE
at risk for unplanned pregnancy about the interactions
of SLE disease as related to pregnancy. At Srinagarind
Hospital, 90% of pregnant women with SLE knew their
diagnosis before getting pregnant. Two-thirds had active
lupus during their pregnancy and 40% had active lupus
even before conception and the pregnancy outcomes
were grave [4]. According to a 2010 report in Auto-
immunity Reviews, [9] lupus pregnancies can be success-
ful, so physicians should introduce a discussion with the
patient about pregnancy and its problems and a multi-
disciplinary team (including rheumatologists, internists,
obstetricians and neonatologists) should take care of the
patient. In the current study, a very small proportion of
patients were referred to family planning, so cooper-
ation of the rheumatologist and obstetrician might re-
duce the number of unplanned pregnancies. Moreover,
the counseling should probably not be just once but an-
nually or even more frequently in the active renal disease
group.
Table 7 Univariable predictors of effective contraception use and receiving contraceptive counseling among women
with systemic lupus erythematosus at risk for unplanned pregnancy*




Age > 30 (vs. ≤ 30) 15 1.24 (0.31-4.93) 0.69 (0.14- 3.35)
Income≥ 10,000 THB (vs. <10,000) 8 2 (0.4-9.9) 2.45 (0.25-23.6)
College degree (vs. less education) 10 1.18 (0.26-5.34) 1.26 (0.21-7.65)
Taking teratogenic medication 8 0.17 (0.02-1.65) 0.85 (0.14-5.39)
Active renal disease (vs. stable disease) 11 0.24 (0.04-1.46) 0.32 (0.05-1.87)
Active non-renal disease (vs. stable disease) 5 0.74 (0.09-5.49) 0.75 (0.06-9.26)
Disease duration > 5 yr (vs. < 5 yr) 13 1.09(0.25-4.50) 2.06(0.35-12.16)
Know about the effect of SLE on pregnancy 27 0.98 (0.19-5.00) 13.33 (2.05-86.34) ¥
Know about the effect of pregnancy on SLE 29 0.52(0.09-3.10) 12.50 (1.69-92.25) ¥
Know about the better prognosis if pregnancy occurs after
6 months of being stable or free of disease
21 1.10 (0.27-4.50) 20 (2.08-192.64) ¥
healthcare provider
• Rheumatologist (vs. no provider) 23 0.88 (1.16-4.71) -
• OB 4 1.66 (0.14-18.87)
Prior pregnancy 24 3.8 (0.67-21.47) 13.2 (2.03-85.81) ¥
Prior induced abortion 5 3 (0.43-20.9) -
Not desire to get pregnant (vs. desire or not considered)
• Women with SLE 25 0.47 (0.08-2.75) 3.5 (0.47-24.65)
• Their partners 1.18 (0.19-6.66) 1.26 (0.17-15.31)
• Their families 10 0.50 (0.07-3.42) 2.64 (0.29-19.51)
27
* Values are the odds ratio (95% confidence interval) unless otherwise indicated. ** Age and disease duration reported using mean difference & 95% confidence
interval. ***Effective contraception included hormonal methods and IUD. ¥ = significant (P < 0.05).
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ommendations for Contraceptives for Women with SLE
indicated that SLE is one of the conditions that makes
unintended pregnancy an unacceptable health risk and
will happen in women at their peak reproductive age.
The role of providers is to assist these women with pro-
viding appropriate information to make decisions on
pregnancy and when they do make a decision to have a
baby, ensure that this is timed when there is less risk
and better follow up.
The important policy is all providers not only the Ob-
Gyn should have an update on contraception, counseling
skills and perhaps develop a protocol that regardless of
who sees these patients at first visit should start assessingTable 8 Multivariate predictors for receiving
contraceptive counseling among women with systemic
lupus erythematosus at risk for unplanned pregnancy*
Odds ratio 95%CI
Know about the effect of SLE on pregnancy 2.80 0.26- 29.47
Know about the effect of pregnancy on SLE 3.41 0.28- 41.39
Know about the better prognosis if pregnancy
occurs after 6 months of being stable or free
of disease
10.34 0.91-118.05risk for pregnancy and help the patient get to the right
person to get effective counseling.
However, the appropriate contraception methods, con-
sistency use and complication of contraception use were
not reviewed, so the further study required.
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